atezolizumab’s role in treating nondriver nsclc
Published 6 years ago • 97 plays • Length 3:15Download video MP4
Download video MP3
Similar videos
-
3:28
advanced-stage nondriver nsclc: impower150 trial
-
2:21
an overview of the birch trial investigating atezolizumab in nsclc
-
3:01
choosing between atezolizumab and pembrolizumab in lung cancer
-
1:50
dr. melissa johnson on atezolizumab in patients with nsclc
-
2:42
second-line immunotherapy in advanced nondriver nsclc
-
4:12
nondriver nsclc: adding pembrolizumab to platinum-based chemotherapy
-
2:57
managing nondriver nsclc treatment with immunotherapy
-
4:02
atezolizumab with chemotherapy in first-line treatment of non-squamous nsclc
-
0:50
considering factors to treat non-driver patients with nsclc with bevacizumab
-
1:39
growing role of immunotherapy as treatment for lung cancer
-
8:20
impower010: atezolizumab versus best supportive care after adjuvant chemotherapy in resected nsclc
-
1:41
adjuvant atezolizumab in nsclc
-
2:36
atezolizumab with erlotinib in combination treatment for egfr mutant nsclc
-
3:07
neoadjuvant atezolizumab in nsclc
-
1:45
dr. chandra belani on atezolizumab in nsclc
-
3:28
atezolizumab with chemotherapy improves pfs in squamous nsclc
-
4:36
quality of life’s role in treating nondriver mnsclc
-
0:59
is adc the answer to lung cancer #2023 #oncology #lungcancer
-
4:18
impower110: atezolizumab vs chemo in pd-l1–selected nsclc